on Antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals.
As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights informs, educates and connects professionals around the globe with the aim to curb Antimicrobial resistance.
AMR Insights is committed to eliminating antimicrobial resistance because it does not accept that millions of innocent people need to die as a result of resistant bacteria and other microorganisms.
Antibiotics, Antimicrobials & Antibiotic Resistance
Theme: Antibiotics: Discovery, Resistance, and Alternatives
20/05/2019 - 21/05/2019 | Tokyo (Japan)
Accelerating antibiotic development in Europe
The Netherlands Antibiotic Development Platform (NADP) is organizing its second annual meeting, titled ‘Accelerating antibiotic development in Europe’.
22/05/2019 - 22/05/2019 | Utrecht (The Netherlands)
Latest news on AMR
Antimicrobial Resistance Information from FDA
According to the Centers for Disease Control and Prevention (PDF, 3.9 MB), each year in the United States at least two million people develop serious infections caused by bacteria resistant to antibacterial drugs, and at least 23,000 people die as a result. Combating AMR requires multifaceted efforts in both the healthcare and veterinary sectors.
Clinical impact of rapid species identification from positive blood cultures with same-day phenotypic antimicrobial susceptibility testing on the management and outcome of bloodstream infections
The Accelerate Pheno™ system (ADX) is a novel technology using fluorescence in-situ hybridization for rapid species identification (ID) and morphokinetic bacterial analysis for phenotypic antimicrobial susceptibility testing (AST) with promising results. Yet the impact of this technology on clinical management and patient outcome remains unclear.
Stay tuned with remarkable global AMR news and developments!